APA (7th ed.) Citation

Braulke, F., Zettl, F., Ziepert, M., Viardot, A., Kahl, C., Prange-Krex, G., . . . Trümper, L. (2022). First-line treatment with bendamustine and rituximab for old and frail patients with aggressive lymphoma: Results of the B-R-ENDA trial. HemaSphere, 6(12), . https://doi.org/10.1097/HS9.0000000000000808

Chicago Style (17th ed.) Citation

Braulke, Friederike, et al. "First-line Treatment with Bendamustine and Rituximab for Old and Frail Patients with Aggressive Lymphoma: Results of the B-R-ENDA Trial." HemaSphere 6, no. 12 (2022). https://doi.org/10.1097/HS9.0000000000000808.

MLA (9th ed.) Citation

Braulke, Friederike, et al. "First-line Treatment with Bendamustine and Rituximab for Old and Frail Patients with Aggressive Lymphoma: Results of the B-R-ENDA Trial." HemaSphere, vol. 6, no. 12, 2022, https://doi.org/10.1097/HS9.0000000000000808.